The International Medical University (IMU) is a private, English language, health sciences university in Kuala Lumpur, Malaysia, and Malaysia's leading private medical and healthcare university. It was established in 1992, and is active in research and teaching within medicine and healthcare with a strong international orientation. IMU is a wholly owned subsidiary of Asia's largest private healthcare group IHH Healthcare, which is majority-owned by the Malaysian government's sovereign wealth fund, Khazanah. The current CEO of IMU is Abdul Aziz Baba.
IMU was the first private higher education institution in Malaysia that received the right to confer academic degrees, and it was granted full university status by the government in 1999. It cooperates with universities in the United Kingdom, Australia, New Zealand, the United States, Canada, Ireland and China.
The main campus of IMU is located in Bukit Jalil, Kuala Lumpur. As of 2017, the university has 21,973 students across its various programmes.
The university offers a range of undergraduate programmes in medical and health sciences: Medicine, dentistry, pharmacy, pharmaceutical chemistry, nursing, nursing science, dietetics with nutrition, nutrition, psychology, biomedical science, medical biotechnology, chiropractic, Chinese medicine as well as postgraduate degrees such as MSc and PhD in Medical and Health Sciences, MSc in Public Health, MSc in Analytical and Pharmaceutical Chemistry and MSc in Molecular Medicine.
Last update 25 February 2021